Frankfurt
24.03.25
09:59 Uhr
0,442 Euro
-0,001
-0,23 %
-0,23 %
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,446 | 0,483 | 13:35 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.03. | Senzime Secures Additional US Hospital System Contracts | 205 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / March 14, 2025 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced that it has secured new important US hospital system contracts including initial delivery of 60 next-generation... ► Artikel lesen | |
| 17.02. | Senzime: Interim report January - December 2024: Our Rapid Growth Journey Continued in 2024 with a 65% Growth Rate | 143 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESS Newswire / February 17, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB's (publ) interim report for January - December 2024 is now available on the company's website www.senzime.com.Financial... ► Artikel lesen | |
| 13.02. | Invitation to Presentation of Senzime's Fourth Quarter 2024 Report | 188 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / February 13, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime invites investors, analysts, and media to a webcast presentation of the fourth quarter report for 2024 on... ► Artikel lesen | |
| 13.01. | Senzime Reaches Second Milestone of Masimo Collaboration with Launch of Integration to Iris Gateway | 368 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESSWIRE / January 13, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ.), a leader in precision-based patient monitoring, today announced that the company has reached a second... ► Artikel lesen | |
| SENZIME Aktie jetzt für 0€ handeln | |||||
| 07.01. | Senzime Secures Multiple New Hospital Contracts for its Next-Generation TetraGraph System | 414 | ACCESS Newswire | UPPSALA, SE / ACCESSWIRE / January 7, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime,an industry leader in precision-based patient monitoring solutions, today announced multiple hospital contract wins... ► Artikel lesen | |
| 03.01. | New Number of Shares and Votes in Senzime AB | 280 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESSWIRE / January 3, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) The number of shares and votes in Senzime AB (publ) ("Senzime") has increased during December due to the directed share... ► Artikel lesen | |
| 06.11.24 | Senzime: Interim Report January - September 2024: Strong Sales Growth Driven by Accelerated Sensor Sales | 195 | ACCESS Newswire | UPPSALA, SE / ACCESSWIRE / November 06, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Press release: Uppsala, November 6th, 2024. Senzime AB's (publ) interim report for January - September 2024 is now available... ► Artikel lesen | |
| 31.10.24 | New Number of Shares and Votes in Senzime AB | 247 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESSWIRE / October 31, 2024 / The number of shares and votes in Senzime AB (publ) (STO:SEZI)(OTCQX:SNZZF) ("Senzime") has increased during October due to the directed share issue... ► Artikel lesen | |
| 30.10.24 | Invitation to Presentation of Senzime's Third Quarter 2024 Report | 313 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESSWIRE / October 30, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) invites investors, analysts, and media to a webcast presentation of the third quarter report for 2024 on November 6... ► Artikel lesen | |
| 23.10.24 | Bulletin From Extraordinary General Meeting in Senzime AB | 205 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESSWIRE / October 23, 2024 / The extraordinary general meeting in Senzime AB (STO:SEZI)(OTCQX:SNZZF) (publ), corp. reg. no 556565-5734 (the "Company") was held on 23 October 2024... ► Artikel lesen | |
| 23.10.24 | Senzime Secures First European Hospital Order for its New Next-Generation TetraGraph System | 229 | ACCESS Newswire | UPPSALA, SWEDEDN / ACCESSWIRE / October 23, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Uppsala, Sweden - Senzime AB announces that it has secured the first order for the just launched next-generation TetraGraph... ► Artikel lesen | |
| 19.10.24 | New Clinical Study Confirms the Industry Leading Performance Of Senzime's TetraGraph System | 575 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESSWIRE / October 19, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Philadelphia, ANESTHESIOLOGY 2024 - A just published US-based study validated Senzime's TetraGraph system for accuracy... ► Artikel lesen | |
| 15.10.24 | Senzime to launch Next-Generation TetraGraph System at ANESTHESIOLOGY 2024 Conference | 387 | ACCESS Newswire | UPPSALA, SE / ACCESSWIRE / October 15, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB, a leader in perioperative patient monitoring solutions, announces the launch of its next-generation TetraGraph... ► Artikel lesen | |
| 27.09.24 | Notice of Extraordinary General Meeting in Senzime AB | 266 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESSWIRE / September 27, 2024 / The shareholders in Senzime AB (publ)(STO:SEZI)(OTCQX:SNZZF) corp. reg. no 556565-5734 (the "Company") are hereby convened to an extraordinary general... ► Artikel lesen | |
| 24.09.24 | Senzime Secures New Contract With Leading US Healthcare System | 320 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESSWIRE / September 24, 2024 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced that it has secured an initial purchasing contract with a hospital of a top 5 US-based Integrated... ► Artikel lesen | |
| 26.08.24 | Senzime Provides Market Update and Outlines High Growth Ambitions | 423 | ACCESS Newswire | UPPSALA, SE / ACCESSWIRE / August 26, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, a pioneer and leader within neuromuscular monitoring, announces updates to its market assessment and growth ambitions.... ► Artikel lesen | |
| 26.08.24 | Senzime: Interim Report January - June 2024: Strong Sales Growth in US Market | 511 | ACCESS Newswire | UPPSALA, SWEDDEN / ACCESSWIRE / August 26, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Press release: Uppsala, 26 August 2024. Senzime AB:s (publ) interim report for January - June 2024 is now available... ► Artikel lesen | |
| 20.08.24 | Invitation to Presentation of Senzime's Second Quarter 2024 Report | 342 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESSWIRE / August 20, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime invites investors, analysts, and media to a webcast presentation of the second quarter report for 2024 on August... ► Artikel lesen | |
| 19.07.24 | Senzime Expands Contract with Leading US Hospital System | 376 | ACCESS Newswire | UPPSALA, SE / ACCESSWIRE / July 19, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in algorithm-based patient monitoring solutions, today announced a new contract with a leading... ► Artikel lesen | |
| 25.06.24 | Senzime Granted New European TetraGraph System Patent | 313 | ACCESS Newswire | UPPSALA, SE / ACCESSWIRE / June 25, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ.) announced today that the European Patent Office (EPO) has issued a new patent protecting unique capabilities... ► Artikel lesen |
Seite:
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 51,48 | -0,54 % | EQS-CMS: Siemens Healthineers AG: Bekanntmachung nach Art. 5 Abs. 1 lit. a) der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung (EU) Nr. 2024/2809 (MAR) i.V.m. Art. 2 Abs. 1 der Delegierten Verordnung (EU) Nr. 2016 | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation
Bekanntmachung nach... ► Artikel lesen | |
| FRESENIUS | 39,260 | -1,03 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Fresenius nach Jahreszahlen von 44 auf 48 Euro angehoben und die Einstufung auf "Buy" belassen. Analyst James Vane-Tempest... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 58,33 | 0,00 % | PROCEPT BioRobotics: WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation Therapy to Laser Enucleation | ||
| GERRESHEIMER | 75,85 | -0,33 % | Übernahmegerüchte: Wird Gerresheimer jetzt geschluckt? | Presseberichten zufolge haben Warburg und KKR ein Übernahmeangebot für Gerresheimer vorgelegt. Jetzt noch schnell einsteigen Den vollständigen Artikel lesen ... ► Artikel lesen | |
| ATRICURE | 33,760 | 0,00 % | 11 Analysts Have This To Say About AtriCure | ||
| FRESENIUS MEDICAL CARE | 44,900 | -0,22 % | EQS-DD: Fresenius Medical Care AG: Helen Pring Giza, Kauf von Aktien unter dem Fresenius Medical Care Management Board Long Term Incentive Plan 2020 (Zuteilung 2022) | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
19.03.2025 / 09:47... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 66,60 | +4,14 % | Aktienmarkt: Kurs der Carl Zeiss Meditec-Aktie im Plus (66,65 €) | Die Carl Zeiss Meditec-Aktie notiert heute ein wenig fester. Das Wertpapier kostete zuletzt 66,65 Euro. Die Aktie von Carl Zeiss Meditec verzeichnet zur Stunde eine Verteuerung von 3,98 Prozent. Sie... ► Artikel lesen | |
| GLUCOTRACK | 0,294 | 0,00 % | Glucotrack, Inc.: Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor | RUTHERFORD, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the design, development, and commercialization... ► Artikel lesen | |
| ALLURION TECHNOLOGIES | 3,680 | 0,00 % | Pre-market Movers: Allurion Technologies, Impact BioMedical, Patriot National Bancorp, TransCode Therapeutics, DSS, Inc. | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.10 A.M. ET).In the Green Allurion Technologies Inc. (ALUR) is up over 64% at... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 17,540 | 0,00 % | Alignment Healthcare for Seniors | ||
| INTUITIVE SURGICAL | 462,00 | +1,48 % | Intuitive Surgical Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
| AGILON HEALTH | 4,490 | 0,00 % | 4 Analysts Have This To Say About Agilon Health | ||
| ECKERT & ZIEGLER | 55,20 | -0,63 % | Eckert&Ziegler-Aktie: Kurs legt zu (58,70 €) | Die Aktie von Eckert&Ziegler notiert heute fester. Der jüngste Kurs betrug 58,70 Euro. Jahreschart der Eckert&Ziegler AG-Aktie, Stand 18.03.2025 Ein Kursgewinn in Höhe von 1,80 Euro erfreut derzeit... ► Artikel lesen | |
| HIMS & HERS HEALTH | 33,720 | +4,72 % | Hims and Hers Aktienanalyse: Kurskapriolen um die Telehealth Aktie | hs_cos_wrapper_widget_ad337f71-ab65-46f5-874c-89176749c0b3 .cta-box { background-color:rgba(245,249,252,100.0); } ðŸ'¡ Das Wichtigste in Kürze Hims and Hers betreibt eine Online-Plattform für ärztliche... ► Artikel lesen | |
| UNITEDHEALTH | 477,70 | -0,15 % | Opening Bell: United Health, Starbucks, Alphabet, Intel, Affirm Holdings, Ferrari | Schwache US-Konjunkturdaten sorgten für positive Impulse an den Märkten. Dies reduzierte Inflationssorgen und weckte Hoffnungen auf stabile oder sinkende Zinsen. Der Dow Jones gewann 0,85 Prozent hinzu... ► Artikel lesen |
SENZIME AB gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,442 Euro und damit -0,23 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SENZIME AB finden Sie auf Wallstreet Online.
